TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Oliver Reimann, PhD
Co-Founder at Belyntic GmbH

Profile

Oliver Reimann did his Ph.D. in organic chemistry, looking at Alzheimer’s Disease relevant post-translational modifications of semi-synthetic tau proteins with Christian Hackenberger at the Leibniz Institute for molecular pharmacology. He is one of the co-founders of Belyntic and his main responsibilities and interests are centralized in the fields of linker production, applications of PEC in divers fields, R&D and sales.

Oliver Reimann, PhD's Network

Agenda Sessions

  • Changing the Tide in Peptides - Peptide Purification and Modification with Belyntic’s Catch-and-Release Technology

    , 12:30